tiprankstipranks
Benitec Biopharma (BNTC)
NASDAQ:BNTC
US Market
BNTC
Benitec Biopharma
RESEARCH TOOLSreports
Want to see BNTC full AI Analyst Report?

Benitec Biopharma (BNTC) Income Statement

317 Followers

Benitec Biopharma Income Statement

Last quarter (Q3 2026), Benitec Biopharma's total revenue was AU$0.00, a decrease of ― from the same quarter last year. In Q3, Benitec Biopharma's net income was AU$-11.94M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 0.00AU$ 0.00AU$ 75.00KAU$ 73.00KAU$ 59.00K
Gross Profit
AU$ 0.00AU$ 0.00AU$ 75.00KAU$ 64.00KAU$ -64.00K
Operating Expenses
AU$ 41.77MAU$ 22.49MAU$ 19.16MAU$ 17.92MAU$ 13.53M
Depreciation and Amortization
AU$ 396.00KAU$ 343.00KAU$ 381.00KAU$ 392.00KAU$ 424.00K
EBITDA
AU$ -41.37MAU$ -22.15MAU$ -18.70MAU$ -17.78MAU$ -13.45M
Operating Income
AU$ -41.77MAU$ -22.49MAU$ -19.08MAU$ -17.85MAU$ -13.60M
Other Income/Expenses
AU$ 3.85MAU$ 739.00KAU$ -481.00KAU$ -354.00KAU$ -286.00K
Pretax Income
AU$ -37.92MAU$ -21.75MAU$ -19.56MAU$ -18.21MAU$ -13.88M
Net Income
AU$ -37.92MAU$ -21.75MAU$ -19.56MAU$ -18.21MAU$ -13.88M
Per Share Metrics
Basic EPS
AU$ -1.05AU$ -2.68AU$ -14.12AU$ -19.31AU$ -27.27
Diluted EPS
AU$ -1.05AU$ -2.68AU$ -14.12AU$ -19.31AU$ -27.27
Weighted Average Shares Outstanding
 36.21M 10.26M 1.39M 1.92M 1.01M
Weighted Average Shares Outstanding (Diluted)
 36.21M 10.28M 1.39M 1.92M 1.01M
Currency in AUD

Benitec Biopharma Earnings and Revenue History